CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,407,664 | +16.6% | 362,687 | -14.4% | 0.00% | 0.0% |
| Q2 2023 | $4,636,898 | -2.0% | 423,461 | -21.9% | 0.00% | 0.0% |
| Q1 2023 | $4,730,000 | +24894636.8% | 542,407 | +18028.6% | 0.00% | – |
| Q4 2022 | $19 | -99.9% | 2,992 | -52.7% | 0.00% | – |
| Q3 2022 | $22,000 | +120.0% | 6,323 | +89.1% | 0.00% | – |
| Q2 2022 | $10,000 | -99.8% | 3,343 | -99.7% | 0.00% | – |
| Q1 2022 | $4,055,000 | -13.2% | 1,303,711 | -5.7% | 0.00% | -100.0% |
| Q4 2021 | $4,674,000 | -3.8% | 1,382,546 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $4,860,000 | +3638.5% | 1,331,275 | +4360.5% | 0.00% | – |
| Q2 2021 | $130,000 | -68.3% | 29,846 | -67.0% | 0.00% | – |
| Q1 2021 | $410,000 | -13.5% | 90,467 | +9.6% | 0.00% | – |
| Q4 2020 | $474,000 | +159.0% | 82,564 | +219.7% | 0.00% | – |
| Q3 2020 | $183,000 | +125.9% | 25,822 | +10.8% | 0.00% | – |
| Q2 2020 | $81,000 | -93.0% | 23,307 | -97.0% | 0.00% | – |
| Q1 2020 | $1,164,000 | +2545.5% | 786,408 | +3382.3% | 0.00% | – |
| Q4 2019 | $44,000 | -98.2% | 22,583 | -95.3% | 0.00% | – |
| Q3 2019 | $2,475,000 | +1775.0% | 483,399 | +2455.0% | 0.00% | – |
| Q2 2019 | $132,000 | -96.6% | 18,920 | -93.6% | 0.00% | -100.0% |
| Q1 2019 | $3,937,000 | +58.5% | 296,503 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $2,484,000 | +1545.0% | 315,726 | +2213.3% | 0.00% | – |
| Q3 2018 | $151,000 | -76.6% | 13,648 | -71.6% | 0.00% | – |
| Q2 2018 | $646,000 | +31.6% | 48,101 | +27.3% | 0.00% | – |
| Q1 2018 | $491,000 | – | 37,785 | +37685.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 100 | -99.6% | 0.00% | – |
| Q2 2015 | $67,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |